Samsung Biologics to separate manufacturing and biosimilar businesses
Samsung Biologics is splitting apart its contract manufacturing and biosimilar development activities in a bid to enhance their competitiveness.
Samsung Bio will become a pure …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.